Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

ASPIRA PATHLAB & DIAGNOSTICS LTD.

NSE : NABSE : 540788ISIN CODE : INE500C01017Industry : Hospital & Healthcare ServicesHouse : Private
BSE66.583.17 (+5 %)
PREV CLOSE () 63.41
OPEN PRICE () 63.40
BID PRICE (QTY) 65.01 (26)
OFFER PRICE (QTY) 66.58 (572)
VOLUME 2101
TODAY'S LOW / HIGH ()63.40 66.58
52 WK LOW / HIGH () 2564
NSE
This Company is not listed in NSE
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1973

Management Info :

Haseeb Drabu - Chairman Pankaj Shah - Managing Director

Registered Office :

Address : Flat No. 2, R D Shah Building,Shraddanand Road, Opp. Ghatkopar Railway Station,Ghatkopar (West),
Mumbai,
Maharashtra-400086

Phone : 022-7197 5756 / 2513 9090

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai
Listing : BSE
NEWS
04Sep Aspira Pathlab & Diagnostics informs a
Aspira Pathlab & Diagnostics has enclosed copies of Newspaper advert..
24Aug Aspira Pathlab & Diagnostics informs a
Aspira Pathlab & Diagnostics has informed that 51st Annual General M..
24Aug Aspira Pathlab & Diagnostics informs a
Aspira Pathlab & Diagnostics has informed that as per the Ministry o..
09Apr Aspira Pathlab & Diagnostics informs a
Aspira Pathlab & Diagnostics has confirmed that Aspira Pathlab &..
19Mar Aspira Pathlab & Diagnostics informs a
Aspira Pathlab & Diagnostics has informed that it enclosed the follo..
Financials
in Millions
QTR Jun 24 ANNUAL 24
Net Profit-0.160000000000005-26.73
Gross Profit -0.160000000000005 -26.73
Operating Profit 4.41999999999999-7.66
Net Sales 46.37132.05
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr Agarwals Eye Hsp (BSE)
 4857.15 (1.69%)
M.Cap ( in Cr)
2282.81
RainbowChildrenS Med (BSE)
 1651.25 (3.25%)
M.Cap ( in Cr)
16881.44
Thyrocare Tech. (BSE)
 985.95 (4.02%)
M.Cap ( in Cr)
5246.65
Vijaya Diagnostic (BSE)
 1045.70 (2.93%)
M.Cap ( in Cr)
10755.05
Apollo Hospital Ent. (BSE)
 6879.95 (0.29%)
M.Cap ( in Cr)
98959.07
Shareholding Pattern
NON-INSTITUTION 81.45%
PROMOTERS 18.55%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77512.92-178.03 (-0.23%)
NIFTY23516.35-42.70 (-0.18%)
Dow Jones 43958.1947.21 (0.11%)
Nasdaq 19230.72-50.68 (-0.26%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI